
Human MAGE 10 254-262, GLYDGMEHL
Description
About Human MAGE 10 254-262, GLYDGMEHL
The Human Melanoma-associated antigen (MAGE) 10 Peptide (IEDB: 189401) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Melanoma-associated antigen (MAGE) Peptide, H-GLYDGMEHL-OH (Uniprot: P43363 aa: 254-262) from JPT is produced under strict quality control and quality management.
Human MAGE 10 254-262, GLYDGMEHL - Specifications
- Peptide sequence: H-GLYDGMEHL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Hepatitis, Melanoma, Ovarian cancer, Lung cancer, Hepatocellular carcinoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human MAGE 10 254-262, GLYDGMEHL
References:
Read References with JPT’s Antigen Peptides
Human MAGE 10 254-262, GLYDGMEHL has been described in:
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate., Oncoimmunology, 2019 (PMID: 30713784)
HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection., Liver Cancer, 2019 (PMID: 30815394)
Recruitment of highly cytotoxic CD8<sup>+</sup> T cell receptors in mild SARS-CoV-2 infection., Cell Rep, 2022 (PMID: 34968416)
Documentation
Documentation for Human MAGE 10 254-262, GLYDGMEHL
Properties
Properties of Human MAGE 10 254-262, GLYDGMEHL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Hepatitis, Hepatocellular carcinoma, Lung cancer, Melanoma, Ovarian cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Melanoma-associated antigen (MAGE) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human MAGE 10 254-262, GLYDGMEHL
Information | Values |
---|---|
Sequence: | H-GLYDGMEHL-OH |
Specifications: | 9mer peptide as TFA salt |